Collections

  • Collection |

    With this collection, Nature Communications, Nature Medicine, Communications Medicine and Scientific Reports aim to publish research articles spanning the breadth of AMR and across microbial pathogens (bacteria, viruses, fungi and parasites). This includes, and is not limited to epidemiological monitoring of resistance incidence in clinical and environmental settings, novel strategies aiming to combat or prevent AMR (i.e. drug repurposing, drug synergy treatment, and vaccines), improvements in diagnostics, and subsequently tailored treatment, of drug-resistant infections.

    Image: ©TopMicrobialStock / stock.adobe.com
    Open for submissions
  • Collection |

    With this Collection, a partnership between Nature, Nature Medicine and Nature Communications, we welcome submissions of primary research papers that focus on neo-adjuvant immunotherapies and related combinatorial approaches (such as radio-immunotherapy or chemo-immunotherapy).

    Image: wildpixel / Getty Images / iStock
    Open for submissions
  • Collection |

    Detailed method reporting is essential for research reproducibility and trust in published results.

    Image: Sam Whitham
  • Collection |

    The 2023 Nobel prize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their “discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19”.

    Image: Springer Nature/The Nobel Foundation/Imagesource
  • Focus |

    Nature Medicine presents a special Focus dedicated to population health in the context of new threats and growing inequities.

    Image: Marina Spence
  • Collection |

    The year 2023 marks the mid-point of the 15-year period envisaged to achieve the Sustainable Development Goals, targets for global development adopted in September 2015 by all United Nations Member States.

    Image: © Springer Nature
    Open for submissions
  • Collection |

    Stem cell models of development, regeneration, and disease are quickly advancing. New technologies and concepts are continuously combined with existing knowledge to create more realistic systems to improve our understanding of these intricate processes. In this collection, we highlight papers published in 2022-2023 across Nature Portfolio journals on topics including embryonic development and stem cells, reproductive biology, synthetic tissues and embryo models, clinical and translational research and tissue stem cells.

    Image: Jean-Baptiste Sibarita, Virgile Viasnoff, and Anne Beghin
  • Collection |

    Cancer is a leading cause of death, accounting for nearly one in six deaths worldwide. Many cancers can be cured, especially if detected early and treated effectively.

    Image: Kateryna Lon/ Science Photo Library/ Getty Images
  • Series |

    New therapeutics and health technologies require fresh approaches to demonstrating safety and efficacy.

    Image: Marina Spence
  • Special |

    It is the age of large biobanks in human genetics.

    Image: Federico Simeoni, Małgorzata Nowicka, Nicola Cerioli, Rupesh Vyas
  • Focus |

    Anthropogenic climate change is a scientific fact. Without immediate action, we are unlikely to meet the target goal of minimizing global warming to 1.5° C. This collection highlights the importance of human behaviour in climate action, mitigation and adaptation.

    Image: elenabs/iStock/Getty Images Plus/Getty; Irina_Strelnikova/iStock/Getty Images Plus/Getty; Mykyta Dolmatov/iStock/Getty Images Plus/Getty; Rudzhan Nagiev/iStock/Getty Images Plus/Getty; artpartner-images/The Image Bank/Getty. Banner design: Valentina Monaco and Bethany Vukomanovic.